Outcomes®’s Post

The Drug Supply Chain Security Act (DSCSA) is a U.S. law aimed at ensuring the integrity and safety of the pharmaceutical supply chain. Thank you to PrimeRx.io team for this latest #podcast update on #DSCSA Enacted as part of the Drug Quality and Security Act in 2013, DSCSA establishes national standards for tracking and tracing prescription medications as they move from manufacturers through wholesalers, distributors, and eventually to pharmacies and patients. Here’s a breakdown of the key requirements:  Product Tracking: DSCSA mandates that all prescription drugs have a standardized, unique identifier (often a 2D barcode) on their packaging. This makes it easier to track medications at each point in the supply chain.  Verification: Each trading partner (manufacturer, wholesaler, dispenser, etc.) must verify that products are legitimate and free from counterfeits before they are distributed.  Enhanced Security: By November 2024, pharmacies and other stakeholders must implement "interoperable" systems for tracking products electronically. This step involves using systems that can communicate seamlessly across the industry.  Documentation: Trading partners need to maintain detailed records of the products they handle and their movements. This helps track and trace drugs if a safety issue or recall occurs.  Overall, DSCSA aims to protect patients by reducing the chances of counterfeit, stolen, or contaminated drugs entering the U.S. supply chain, making it safer and more transparent.

🎙 Something Big Is Coming... Are you ready to dive deep into the mind of Nicolette? Our CEO steps into the spotlight on the next episode of Bottom Line Pharmacy Podcast to unveil how your independent pharmacy can drive profitability in 2024. 🚀 Stay tuned, you won't want to miss this. #atrium24 #dotti #PharmacySales

Listen Here: https://lnkd.in/gNHaHTgA In this episode, Molly Gamble, Vice President of Editorial at Becker's Healthcare, shares an update on GLP-1 drug coverage policies going into 2025. For more information about Becker's Healthcare, please contact Jessica Cole or Scott Becker. #podcast #healthcarenews #ozempic #glp1

Now available: the latest episode of the PRIME-ROSE podcast titled "Breaking barriers: The PRIME-ROSE project and off-label drug innovations". Sahar Barjesteh van Waalwijk van Doorn-Khosrovani from the CZ (insurance company in the Netherlands) and Hans Gelderblom from the #DRUP trial explain how PRIME-ROSE is working on solutions to tackle the challenges with off-label reimbursement.

With the first round of CMS price negotiations behind us, and the next list of targets to be released in February 2026, it’s clear that theorized implications from the Inflation Reduction Act are becoming reality for the life sciences industry. In this episode, Jen Burke and Mindy McGrath are joined by Putnam Partner, Scott Briggs, to explore how companies can navigate the new pricing pressures and negotiation frameworks while continuing to innovate and ensure patient access to critical therapies. Tap the link to listen: https://lnkd.in/euFP2b-F #Pharma #DrugPricing #MarketAccess #Podcast

BetterWay is coming to Boston! Stop by booth #1119 to meet Nicholas Turos, Pharm D and Kristie Stanton and learn how BetterWay is making convenient, accurate blood testing a reality in the pharmacy. If you have an innovative viewpoint to share, take a seat with Todd S. Eury from Pharmacy Podcast Network. Let's talk #pharmacy and #accessibility!

🔔 It's time of the week: The 4th episode of #IDDI Podcast Series: Accelerated Approvals just dropped! Tune in to hear from Everardo Saad, Vincent Staggs and Sarah Hale, PhD as they explored the significant role of Endpoints in achieveing AA! 🔊 Listen now: https://lnkd.in/ejdjamd3 #biometricscro #trialdesign #biostatistics #acceleratedapprovals #fdaapproval #biopharma #biotechs #pharmaceuticals #endpoints #clinicaltrials #clinicalresearch #datascience

Drug pricing is a complicated topic, to say the least. This podcast episode with Kevin Outterson does a great job of explaining why drug prices are high in the US (and what can happen when prices are too low). https://lnkd.in/efTyTMsM

Let's assume you fully believe med affairs needs to get outside the bubble of our own making. How do you go about doing this? Dr. Samin Saeed and I discussed a whole bunch of practical advise on the latest Pharma Sessions episode. Here's a clip...but listen to the whole thing for much more!

As we begin 2025, did you catch The #PJPod’s final episode of 2024? Here, the editorial team looks back over some of the most significant stories in pharmacy in the past 12 months, before members making their predictions for 2025. What are your predictions and what do you think of the team's? Listen to the episode here | https://lnkd.in/eXDM_xFA #pharmacy #pharmacist #pharmacytechnician #pharmacypractice #clinicalpractice #prescribing